The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccsys Tech Regulatory News (AXS)

Share Price Information for Accsys Tech (AXS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 57.00
Bid: 57.00
Ask: 58.00
Change: -0.20 (-0.35%)
Spread: 1.00 (1.754%)
Open: 57.00
High: 57.20
Low: 57.00
Prev. Close: 57.20
AXS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Commercial Agreements with Cerdia Produktions GmbH

24 Feb 2020 07:00

RNS Number : 8180D
Accsys Technologies PLC
24 February 2020
 

AIM: AXS

Euronext Amsterdam: AXS

 

24 February 2020

 

Accsys Technologies PLC

("Accsys", the "Group" or the "Company")

 

Commercial Agreements with Cerdia Produktions GmbH(formerly known as Rhodia Acetow)

 

Accsys, the fast-growing and eco-friendly company that combines chemistry and technology to create high performance, sustainable wood building products, announces that it has entered into an agreement with Cerdia Produktions GmbH ("Cerdia"), under which Accsys will take on responsibility for commercial activities under agreements with Cerdia relating to Accoya® wood, which will terminate on 1 April 2020 (the "Termination Agreement"). The original agreements, being a licence agreement entered into in 2012, alongside supporting sales and marketing, offtake and exclusivity agreements entered into in 2015, allowed for early termination in certain circumstances in November 2020, with the offtake agreement originally due to expire in December 2020. In bringing forward termination to 1 April 2020, Accsys will be able to sell Accoya® directly into central Europe and Scandinavia approximately 9 months earlier than previously provided for.

Under the terms of the Termination Agreement, payments to Accsys include fees of €3.2 million, to be applied to and set-off against the loan from Cerdia agreed in 2015, which currently amounts to approximately €8.6 million. As a result, Accsys' net debt will be reduced and the Cerdia loan will remain in effect until maturity in 2025.

Accsys is now liaising with European Accoya® customers and other stakeholders to ensure a smooth transition of direct Accoya® sales and marketing relationships from Cerdia, effective from 1 April 2020. 

With Accoya® demand continuing to exceed capacity, the Termination Agreement reflects Accsys' strategic plans to increase its own global manufacturing capacity and distribution network, with further expansion at its Accoya® production facility in Arnhem now in the advanced stages of planning, and discussions progressing with Eastman Chemical Company in relation to a potential new Accoya® plant in North America. The Termination Agreement also follows Cerdia's own renewed focus on its core chemicals businesses following its sale by Solvay to Blackstone in 2017.

Accsys looks forward to continuing to work with Cerdia both during this period of transition and thereafter, exploring with Cerdia other areas of potential cooperation.

Accsys confirms that trading is in-line with the Board's expectations and no changes are being made to the Board's expectations for the full year.

Ends

For further information, please contact:

Accsys Technologies PLC

Robert Harris, CEO

William Rudge, FD

 

via FTI Consulting

Numis Securities Limited -Nominated Adviser and

Joint Broker

Oliver Hardy (NOMAD)

Ben Stoop

Oliver Cox

 

 

+44 (0) 20 7260 1000

 

 

Investec Bank plc - Joint Broker

 

Carlton Nelson

James Rudd

Alex Wright

 

 

+44 (0) 20 7597 5970

FTI Consulting

Matthew O'Keeffe

Alex Le May

 

+44 (0) 20 3727 1340

 

Off the Grid (The Netherlands)

Frank Neervoort

Yvonne Derkse

 

+31 681 734 236

+31 622 37 96 66

 

Notes to editors:

 

Accsys Technologies PLC (www.accsysplc.com) is a chemical technology group whose primary focus is on the production of Accoya® wood and Tricoya® wood elements, technology licensing via its subsidiary, Titan Wood Limited, which has manufacturing operations in Arnhem, the Netherlands (through its subsidiary Titan Wood B.V.), a European office in London, United Kingdom, an American office in Dallas, Texas (via its subsidiary Titan Wood, Inc.) and technology licensing associated with the acetylation of wood elements via its subsidiary Tricoya Technologies Limited. Any references in this announcement to agreements with Accsys shall mean agreements with either Accsys or its subsidiary entities unless otherwise specified. Accsys Technologies PLC is listed on the London Stock Exchange AIM market and on Euronext Amsterdam, under the symbols 'AXS'. Accsys' operations comprise four principal business units: (i) Accoya® wood production; (ii) building and operating of Tricoya® wood chip acetylation plant in Hull; (iii) technology development, focused on a programme of continuous development of and improvements to the process engineering and operating protocols for the acetylation of solid wood and the development of technology for the acetylation of wood elements; and (iv) the licensing of technology for the production of Accoya® wood and Tricoya® wood elements across the globe.

Tricoya® Consortium In March 2017, Accsys announced the formation of the Tricoya® Consortium to fund, build and operate the Tricoya® plant in Hull, UK. Members of the consortium include BP and the leading manufacturer of sustainable wood-based panels, MEDITE Europe DAC. Tricoya Ventures UK Ltd (TVUK), a subsidiary of Accsys, owns and will operate the Tricoya® plant. TTL exploits all Tricoya® related intellectual property and benefits from any Tricoya® related revenues other than those generated by the Tricoya® plant. The Tricoya® plant is expected to have an initial capacity of 30,000 metric tonnes of Tricoya® chips per annum, enough to produce approximately 40,000m3 of Tricoya® panel products per annum. The Tricoya® plant is expected to reach EBITDA breakeven at approximately 40% design capacity and to take approximately four years to reach full capacity following completion. The location of the Tricoya® plant at Saltend Chemicals Park in Hull allows for expansion when market conditions dictate.

 

Accoya®Wood (www.accoya.com) is produced using Accsys' proprietary patented acetylation technology that effectively converts sustainably grown softwoods and non-durable hardwoods into what is best described as a "high technology wood". Distinguished by its durability, dimensional stability and, perhaps most importantly of all, its reliability (in terms of consistency of both supply and quality), Accoya® wood is particularly suited to exterior applications where performance and appearance are valued. Moreover, the Accoya® wood production process does not compromise the wood's strength or machinability. The combination of dimensional stability, durability and retained strength means that Accoya® wood offers a wealth of new opportunities to architects, designers and specifiers. These benefits result in lower maintenance and total cost of ownership while using a higher sustainable and environmental responsible building material. For a full archive of Accoya® news, visit www.accoya.com/news.

Tricoya® Wood Elements (www.tricoya.com) are produced using Accsys' proprietary technology for the acetylation of wood chips and particles for use in the fabrication of panel products such as medium density fibreboard and particle-board. These products demonstrate enhanced durability and dimensional stability which allow them to be used in a variety of applications that were once limited to solid wood or man-made products. Exploitation of Accsys' proprietary technology relating to Tricoya® Wood Elements is carried out through Tricoya Technologies Limited. Tricoya® Wood Elements are lauded as the first major innovation in the wood composites industry in more than 30 years.

Wood Acetylation is a process which increases the amount of 'acetyl' molecules in wood, thereby changing its physical properties. When carried out to a sufficient level throughout the wood, this process protects wood from rot by making it "inedible" to most micro-organisms and fungi, without - unlike conventional treatments - making it toxic. It also greatly reduces the wood's tendency to swell and shrink, making it less prone to cracking and ensuring that, when painted, it requires dramatically reduced maintenance.

 

'Accsys' and 'AccsysTechnologies'aretrading names of Titan Wood Limited. ACCOYA®, TRICOYA® and the Trimarque Device are registered trademarks owned by Titan Wood Limited ("TWL"), a wholly owned subsidiary of Accsys Technologies PLC, and may not be used or reproduced without written permission from TWL, or in the case of the Tricoya® registered trademark, from Tricoya Technologies Limited, a subsidiary of TWL with exclusive rights to exploit the Tricoya® brand.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGREAPAFALLEEFA
Date   Source Headline
22nd Jul 20204:44 pmRNSNotifiable Interest - De Engh B.V.
21st Jul 20207:00 amRNSBoard Appointment of Alexander Wessels
15th Jul 20205:59 pmRNSDirector Interests and LTIP Awards
30th Jun 20209:16 amRNSTotal Voting Rights
23rd Jun 20203:58 pmRNSIssue of Shares and Directors' Interests
23rd Jun 20207:14 amRNSPreliminary Results for the year ended 31 March 20
15th Jun 20205:37 pmRNSNotifiable Interest – Teslin
29th May 20205:37 pmRNSTotal Voting Rights
19th May 20207:00 amRNSAppointment of Chairman Designate
12th May 20204:03 pmRNSNotifiable Interest - BGF
7th May 202011:08 amRNSIssuance of Shares
27th Mar 202012:03 pmRNSCOVID-19 Update
4th Mar 20209:36 amRNSNotifiable Interest - De Engh B.V.
28th Feb 202010:26 amRNSTotal Voting Rights
24th Feb 20207:00 amRNSCommercial Agreements with Cerdia Produktions GmbH
17th Feb 20202:18 pmRNSNotifiable Interest - De Engh B.V.
4th Feb 20203:46 pmRNSEmployee Share Participation Plan
27th Dec 20197:00 amRNSNotifiable Interest - De Engh B.V.
27th Dec 20197:00 amRNSNotifiable Interest - Janus Henderson Group
24th Dec 201910:11 amRNSNotifiable Interest - Pershing Securities Limited
23rd Dec 20192:00 pmRNSDirector Dealings
23rd Dec 20197:00 amRNSAdmission and Total Voting Rights
20th Dec 201910:07 amRNSSuccessful Results of General Meeting
20th Dec 20197:00 amRNSResults of Firm Placing and Placing and Open Offer
2nd Dec 201911:14 amRNSDirector Interests and LTIP Awards
28th Nov 20192:16 pmRNSPublication of a Prospectus
28th Nov 20197:01 amRNSInterim Results for six months ending 30 Sept 2019
28th Nov 20197:00 amRNSEquity Raise
18th Oct 20197:00 amRNSAppointment of Chief Executive Officer
30th Sep 20195:17 pmRNSAGM Results
30th Sep 20197:00 amRNSAGM Statement
17th Sep 20196:03 pmRNSNotifiable Interest - Majedie Asset Management
12th Aug 20193:13 pmRNSAGM Notification
2nd Aug 20197:00 amRNSNotifiable Interest - Teslin Participaties
17th Jul 201911:27 amRNSShare purchase by a PDMR
28th Jun 201912:04 pmRNSShare Purchase by PCA
25th Jun 20195:58 pmRNS20190625 - AXS - Directors Interest LTIP
25th Jun 20197:00 amRNSDirectorate Change
25th Jun 20197:00 amRNSPreliminary results for year ended 31 March 2019
30th Apr 20197:00 amRNSAppointment of joint broker
29th Mar 20199:01 amRNSTotal Voting Rights
25th Mar 20197:00 amRNSTrading Update Year Ending March 2019
4th Mar 20195:31 pmRNSShare purchase by a PCA
15th Feb 20197:00 amRNSIssuance of Shares
9th Jan 20197:00 amRNSAgreement with PCG to evaluate Tricoya® plant
21st Dec 20187:03 amRNSResignation of Director
20th Nov 20187:00 amRNSInterim Results for six months ending 30 Sept 2018
24th Sep 20187:00 amRNSAGM Correction Statement
18th Sep 20184:00 pmRNSAGM - Proxy Results
18th Sep 20187:00 amRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.